Response by Lei et al to letter regarding article, "Modernized Classification of Cardiac Antiarrhythmic Drugs"

Response by Lei et al to letter regarding article, "Modernized Classification of Cardiac Antiarrhythmic Drugs"

Bibliographische Detailangaben
Hauptverfasser:	Lei, M, Wu, L, Terrar, D, Huang, C
Format:	Journal article
Sprache:	English
Veröffentlicht:	American Heart Association 2019

Ähnliche Einträge

Letter to the editor regarding the article of Chen et al.
von: Mehmet Sami Islamoglu, et al.
Veröffentlicht: (2022-12-01)

Cardiac Arrhythmias and Antiarrhythmic Drugs: An Autophagic Perspective
von: Joanne J. A. van Bavel, et al.
Veröffentlicht: (2018-02-01)

Arrhythmia Models for Drug Research: Classification of Antiarrhythmic Drugs
von: Keitaro Hashimoto
Veröffentlicht: (2007-01-01)

Letter by Antoniades et al regarding article, "Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction".
von: Antoniades, C, et al.
Veröffentlicht: (2010)

Letter by Rider and Neubauer regarding article, "Cardiac remodeling in obesity".
von: Rider, O, et al.
Veröffentlicht: (2013)

Antiarrhythmic medication classification based on pathogenetic cardiac arrhythmia mechanisms
von: T. N. Lipnitsky, et al.
Veröffentlicht: (2007-12-01)

Antiarrhythmic medication classification based on pathogenetic cardiac arrhythmia mechanisms
von: T. N. Lipnitsky, et al.
Veröffentlicht: (2007-12-01)

Modernised classification of cardiac anti-arrhytmic drugs
von: Lei, M, et al.
Veröffentlicht: (2018)

Response by Peterzan et al to letter regarding article, “Cardiac energetics in patients with aortic stenosis and preserved versus reduced ejection fraction”
von: Peterzan, MA, et al.
Veröffentlicht: (2020)

Letter to the Editor Regarding Vaping Article
von: Rabbi Yehuda Spitz
Veröffentlicht: (2019-10-01)

Maastricht antiarrhythmic drug evaluator (MANTA): A computational tool for better understanding of antiarrhythmic drugs
von: Sutanto, H, et al.
Veröffentlicht: (2019)

A Letter to the Editor on the Article by Farnam et al
von: Anne Rutte, MSc, et al.
Veröffentlicht: (2015-06-01)

Interactions that matter: 10 Antiarrhythmic drugs
von: Aronson, J
Veröffentlicht: (1987)

Letter regarding article by Becker et al, "Hyperhomocysteinemia, a cardiac metabolic disease: role of nitric oxide and the p22phox subunit of NADPH oxidase".
von: Antoniades, C, et al.
Veröffentlicht: (2005)

Letter to the Editor regarding Cunningham et al. 2020
Veröffentlicht: (2021-04-01)

Effects of Antiarrhythmic Drugs on Apoptotic Pathways in H9c2 Cardiac Cells
von: Shojiro Isomoto, et al.
Veröffentlicht: (2006-01-01)

A review on plants and herbal components with antiarrhythmic activities and their interaction with current cardiac drugs
von: Ahmad Beik, et al.
Veröffentlicht: (2020-05-01)

An algorithm for the selection of antiarrhythmic drugs for clinical pharmacologist
von: A. A. Upnitskiy
Veröffentlicht: (2014-12-01)

Antiarrhythmic Drug Dosing in Children—Review of the Literature
von: Nathalie Oeffl, et al.
Veröffentlicht: (2023-05-01)

Letter to the editor—Opinion on article by Rodriguez-Alvarez F et al.
von: Santiago Rodríguez Villafuerte, et al.
Veröffentlicht: (2025-01-01)

A Letter to the Editor on the Article by Farnam et al.—Author's Response
von: Farnam Farnaz, PhD, et al.
Veröffentlicht: (2015-09-01)

PROPAFENONE, A NEW EFFECTIVE ANTIARRHYTHMIC DRUG. REPORT OF 2 YEARS CLINICAL EXPERIMENT WITH PROPAFENONE (WITH BRIEF REVIEW OF ARTICLES)
von: IRAJ NAZERY , et al.
Veröffentlicht: (1986-12-01)

PROPAFENONE, A NEW EFFECTIVE ANTIARRHYTHMIC DRUG. REPORT OF 2 YEARS CLINICAL EXPERIMENT WITH PROPAFENONE (WITH BRIEF REVIEW OF ARTICLES)
von: IRAJ NAZERY, et al.
Veröffentlicht: (1986-05-01)

Letter to the Editor regarding article Health effects of voluntary exposure to cold water – a continuing subject of debate, by Espeland, et al
von: Richard A. Reinhart
Veröffentlicht: (2023-12-01)

Historical Aspects of the Use of Antiarrhythmic Drugs in Clinical Practice
von: V. L. Doshchitsin, et al.
Veröffentlicht: (2022-07-01)

Safety and interaction of direct oral anticoagulants with antiarrhythmic drugs
von: B. A. Tatarsky, et al.
Veröffentlicht: (2021-08-01)

Antiarrhythmic Drug Use in Pregnancy: Considerations and Safety Profiles
von: Marco Valerio Mariani, et al.
Veröffentlicht: (2024-08-01)

Antiarrhythmic Drug Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy
von: Sean P. Gaine, et al.
Veröffentlicht: (2023-04-01)

Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging
von: Gheorghe-Andrei Dan, et al.
Veröffentlicht: (2018-12-01)

Impact of Antiarrhythmic Drugs on the Outcome of Short QT Syndrome
von: Ibrahim El-Battrawy, et al.
Veröffentlicht: (2019-08-01)

Electrophysiological Effects of a New Antiarrhythmic Drug Aksaritmin
von: Ravshanbek D. Kurbanov, et al.
Veröffentlicht: (2019-06-01)

Impact of Antiarrhythmic Drugs on Complex Fractionated Atrial Electrograms
von: Koichiro Kumagai, MD, et al.
Veröffentlicht: (2011-01-01)

Initiation and outcomes with Class Ic antiarrhythmic drug therapy
von: Xu Gao, et al.
Veröffentlicht: (2018-03-01)

Letter to the Editor in regard to the “Effects of COVID-19 on in-hospital cardiac arrest: incidence, causes, and outcome” by Roedl et al.”
von: A. D. Krieg, et al.
Veröffentlicht: (2021-11-01)

Response to letter by Campbell et al. regarding the results of the COSTICK trial
von: Andrew Smyth, et al.
Veröffentlicht: (2023-07-01)

Reply letter to “response to article by Johnna Perdrizet et al.” by Gomez and colleagues
von: Johnna Perdrizet, et al.
Veröffentlicht: (2022-01-01)

ADJUSTMENT OF PHARMACOLOGICAL ANTIARRHYTHMIC THERAPY IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION DURING SERIAL TESTING OF ANTIARRHYTHMIC DRUGS WITH TRANSESOPHAGEAL ELECTROPHYSIOLOGICAL STUDIES
von: K. A. Skiba, et al.
Veröffentlicht: (2003-06-01)

A letter to the editor regarding the original article by Costa et al: Psychological support, puberty suppression, and psychosocial functioning in adolescents with gender dysphoria
von: Biggs, M
Veröffentlicht: (2019)

Letter to the Editor regarding article “Electrocardiographic markers of increased risk of sudden cardiac death in patients with COVID‐19 pneumonia”
von: Fenglin Jiang
Veröffentlicht: (2021-07-01)

Response by Shimura et al. to the letter regarding article “Calculated plasma volume status and outcomes in patients undergoing transcatheter aortic valve replacement”
von: Tetsuro Shimura, et al.
Veröffentlicht: (2021-08-01)